Design [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-08-27 16:07 (415 d 18:31 ago) – Posting: # 21893
Views: 2,869

Dear All,

We are thinking to perform steady state BE study for XXX submission where Test product is ER formulation and Reference product is IR formulation. Further, Its HVD product. So, question is whether is this feasible to conduct replicate BE IR vs ER and if yes then what are the parameters for conclusion?

Thanks.

Complete thread:

Activity
 Admin contact
21,730 posts in 4,544 threads, 1,543 registered users;
online 16 (0 registered, 16 guests [including 3 identified bots]).
Forum time: Sunday 10:38 CEST (Europe/Vienna)

Be very, very careful what you put into that head,
because you will never, ever get it out.    Thomas Wolsey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5